Metoclopramide Noridem (Metoclopramide Hydrochloride Monohydrate)

Metoclopramide blocks dopamine D2 receptors in the chemoreceptor trigger zone, reducing the central drive for nausea and vomiting. It also stimulates acetylcholine release in the gut, enhancing coordinated peristalsis and accelerating gastric emptying. Weak antagonism of 5‑HT3 receptors and agonism of 5‑HT4 receptors further support its anti‑emetic and pro‑kinetic actions.

The appropriate dose and dosing schedule are determined by the prescribing clinician based on the patient’s condition, age, renal function and route of administration. Metoclopramide is typically given as a short‑term intravenous or intramuscular injection, and the prescriber will adjust the amount and frequency to achieve the desired therapeutic effect while minimizing risk.

Safety data for metoclopramide in pregnancy are limited, and the drug should only be used when the potential benefit justifies any possible risk to the fetus. It is excreted in breast milk, so caution is advised for nursing mothers; a healthcare professional should evaluate the risk‑benefit balance before prescribing.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and assistance with import documentation.

Compared with serotonin‑type 5‑HT3 antagonists such as ondansetron, metoclopramide offers both anti‑emetic and pro‑kinetic effects, making it useful for conditions involving delayed gastric emptying. However, it carries a higher risk of extrapyramidal side effects, especially with prolonged use, whereas 5‑HT3 blockers are generally better tolerated but lack pro‑kinetic activity.

The injectable product should be stored at ambient temperature, protected from excessive heat, moisture and light. Keep the vials in their original packaging until use, and discard any solution that appears discolored or contains particles. Follow standard aseptic techniques when preparing the dose for injection.

Metoclopramide Noridem is supplied as a sterile solution for intramuscular or intravenous injection. The healthcare professional selects the appropriate route, dilutes the medication if required, and administers it over the recommended period, typically as a short infusion for IV use or a quick IM injection. Administration is performed under clinical supervision.

The most concerning adverse reactions include tardive dyskinesia, a potentially irreversible movement disorder, and neuroleptic malignant syndrome, a life‑threatening condition characterized by fever, muscle rigidity and autonomic instability. Early recognition of extrapyramidal symptoms and prompt discontinuation are essential to reduce these risks.

Metoclopramide is contraindicated in patients with known hypersensitivity to the drug or its excipients, in those with pheochromocytoma, and in individuals with a history of severe extrapyramidal reactions. Caution is also advised for patients with gastrointestinal obstruction, perforation, or severe renal impairment, and it should be avoided in pediatric patients unless specifically indicated.